Trial Profile
Octreotide in patients with pancreatic cancer and malignant biliary obstruction undergoing endoscopic retrograde cholangiopancreatography with pancreatic duct stent placement
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2013
Price :
$35
*
At a glance
- Drugs Octreotide (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 27 Aug 2013 New trial record